Adenocarcinoma of the esophagus and gastroesophageal junction: The evolving treatment landscape for locally advanced and metastatic disease in the era of immune checkpoint inhibitors and biomarker‐driven therapeutics - Laura V. M. Baum; Kimberly L. Johung; Joanna Gibson; Gabriel Cartagena; Daniel J. Boffa; Jill Lacy (CA: A Cancer Journal for Clinicians, 2026)